Post-Transplant Cyclophosphamide after Bone Marrow Transplantation is not Associated with an Increased Risk of Donor Derived Malignancy

Post-transplant cyclophosphamide (PTCy) can be used for graft versus host disease (GVHD) prophylaxis alone or in combination with other agents and is associated with excellent rates of engraftment, acute and chronic GVHD, and an absence of post-transplant lymphoproliferative disease. No study has pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biol Blood Marrow Transplant
Hauptverfasser: Majzner, Robbie G., Mogri, Huzefa, Varadhan, Ravi, Brown, Patrick, Cooke, Kenneth R., Bolaños-Meade, Javier, Swinnen, Lode, Kanakry, Jennifer, Luznik, Leo, Jones, Rick, Fuchs, Ephraim, Ambinder, Rich, Kasamon, Yvette, Symons, Heather J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2017
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5632950/
https://ncbi.nlm.nih.gov/pubmed/28062216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.12.640
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge